본문 바로가기 주메뉴 바로가기 하단메뉴 바로가기

GC녹십자MS

  • Contact / Q&A
  • recruitment
  • KOREA
  • SITEMAP
  • Company Introduction
  • Product Information
  • R&D
  • CSR
  • INVESTORS
 

Product Information

We visualize vision through specialized competetion of Green Cross Medical Science

Category 1
Category 2
    Category 3
      QUICK SEARCH
       

      COVID-19

      인쇄
      COVID-19 > GENEDIA W COVID-19 Ag > GENEDIA W COVID-19 Ag
      GENEDIA W COVID-19 Ag
      The GENEDIA W COVID-19 Ag is a lateral flow immunochromatographic assay intended for qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 in nasopharyngeal swab specimens directly collected from individuals who are suspected of COVID-19 by a healthcare provider within the first seven (7) days of symptom onset or for screening of individuals without symptoms or other reasons to suspect COVID-19 infection.

      • Allow wider testing with fast test time (10 minutes)
      • Clinically proven data of asymptomatic patients available
      • Separately packed extraction solution to minimize the possibility of contamination
      • No additional instruments required
      How to test GENEDIA W COVID-19 Ag : https://youtu.be/sLHzdOld5M